Katarina Ziakova: The WFH Shared Decision – Making Tool Is Driving Critical Conversations in Haemophilia Care
Katarina Ziakova, Global Lead, Patient Advocacy for Rare Bleeding Disorders at Novo Nordisk, shared a post on LinkedIn:
“The WFH shared decision – making tool is helping drive a critical conversation in haemophilia care:how do we make treatment discussions more practical, more meaningful, and more centred on what matters most to the people living with haemophilia?
Proud that Novo Nordisk brought together Patient Organization Representatives and HCPs alongside WFH Congress 2026 for an educational event focused on shared decision-making.
What made this especially powerful was that our speakers represented three essential perspectives in haemophilia care: patients, physicians and nurses.
Together, we explored the key questions behind SDM – where to start, why it matters, and how it can be implemented in practice.
For me, this is what patient-centred care looks like: better conversations, stronger partnerships, and decisions that reflect real needs, priorities, and trade – offs.
Grateful for an evening of insight, exchange, and meaningful connection with the haemophilia community!”

Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV